Skin Self-Exam Adherence: What Helps High-Risk Patients?
Performing regular skin checks is frequently recommended for individuals at an increased likelihood of developing skin malignancies. However, building and maintaining a reliable self-examination routine is often challenging. Understanding how medical researchers test and encourage consistent skin checks helps highlight the tools that support long-term habits, as well as where clinical evidence is still lacking.
What was the focus of this skin self-examination review?
To evaluate how interventions encourage ongoing monitoring, a 2023 scoping review published in JAMA Dermatology examined randomized clinical trials addressing self-management practices in people at elevated risk of melanoma. The investigators searched four medical databases—MEDLINE, Embase, CENTRAL, and CINAHL—from their inception through July 2022.
From an initial total of 939 screened records, the review identified 18 eligible randomized clinical trials. Trial participant counts ranged from 40 to 724 individuals. Participants met high-risk criteria based on a family history of melanoma, personal history (such as dysplastic naevus syndrome, an organ transplant, or previous melanoma), a formal risk assessment tool, or clinical judgment. The objective was to catalog the strategies used to support adherence to self-monitoring and review how trial teams measured and reported adherence data.
How did clinical trials attempt to improve adherence?
The review classified interventions using an adaptation of the World Health Organization framework for clinical adherence. Across the 18 clinical trials, researchers introduced techniques categorized across multiple areas:
- Intervention design: Included in all 18 trials to make self-examination protocols clearer or more structured.
- Participant support: Used in all 18 trials to offer direct guidance or resources to the individual.
- Trial design: Employed in 15 trials to align study procedures with participant follow-through.
- Intervention and condition support: Implemented in 10 trials to address medical context and ongoing condition needs.
- Social and economic support: Reported in 5 trials to help mitigate external obstacles.
Looking specifically at behavioral support tools, the trials relied on a few targeted approaches. Reminders were the most common technique, appearing in 8 trials. In addition, 5 trials used priority-setting guidance, and 5 trials incorporated clinician feedback to help reinforce self-examination routines.
How was self-monitoring adherence measured?
Tracking whether participants actually performed their skin checks remains a challenge in clinical research. In most of the included studies, measurement relied on participant self-reports describing their skin self-examination practice. While self-reporting is straightforward, it can introduce reporting bias.
More recently, trials evaluating digital tools implemented direct tracking. Some digital interventions measured user engagement directly by gathering analytic data from mobile applications or websites. This allowed investigators to see objective user activity rather than depending entirely on retrospective memory.
What limitations and gaps did the review uncover?
While many trials introduced methods to encourage regular checks, the review emphasized that there is sparse evidence on the actual effectiveness of these individual strategies. Because trials frequently combined multiple techniques, isolating which specific tool drove adherence was difficult.
The authors also pointed out significant reporting gaps. Fewer than half of all the reviewed reports mentioned adherence in their discussion sections. Furthermore, only 5 trials addressed provider adherence—meaning the consistency of clinicians and researchers in delivering the interventions.
Equity gaps were equally prominent. The scoping review found no strategies reported for supporting adherence among underserved groups, such as older adults, non-English speakers, individuals with low health literacy, or people facing socioeconomic disadvantages. To address these limitations, the authors suggested that future research could evaluate specific adherence tools using a Study Within A Trial (SWAT) design within host trials.
How does this apply to personal skin health?
For individuals navigating personal risk factors—such as a personal or family history of skin cancer—learning the basics of a self-exam remains a key component of self-care. Reviewing suspicious spots using structured methods like the ABCDE mole check helps people spot evolving marks early, while understanding the different types of skin cancer provides context on what changes warrant attention.
At the same time, lifestyle choices should not replace medical oversight. Products sold online for cosmetic tanning, such as unapproved and unregulated melanotan peptides, do not eliminate risk and carry unknown health profiles. Anyone managing elevated melanoma risk should consult a board-certified dermatologist or primary care doctor to establish an individualized surveillance schedule rather than relying solely on self-management.
Overall, as shown in the JAMA Dermatology scoping review, establishing consistent self-examination habits often benefits from tools like scheduled reminders and clinician feedback, but more rigorous testing is needed to prove which approaches work best over time.
Sources
Published October 28, 2026. Sources are linked in the text. See our Medical Disclaimer.